Gender-Affirming Care Becomes a Political Indicator for Top Medical Groups
The American Medical Association (AMA) continues to endorse gender‑affirming care, a position it has reiterated over the past decade. Republican attorneys general from twenty states have written to the AMA demanding it oppose such care for minors, citing potential violations of consumer‑protection laws. The pressure intensified after a January meeting with Dr. Mehmet Oz and the Centers for Medicare and Medicaid Services, which some interpreted as a shift toward restriction. The dispute highlights how medical group statements are becoming political litmus tests.
Morning Headlines 4/3/26
A new executive title, Chief Health AI Transformation Officer (CHAITO), is emerging as health systems prioritize artificial‑intelligence integration. Industry insiders debate whether AI should simply reduce appointment volume or enhance care pathways, highlighting the nuance between scheduling fewer visits and...
Parents Spend $50k on Overseas Stem Cell Therapy as Experts Issue Warning
Australian parents spent roughly US$33,000 on a stem‑cell procedure in Thailand for their five‑year‑old son with septo‑optic dysplasia, a rare eye condition affecting only 54 Australians. After multiple treatments, the child’s visual acuity improved from 1/60 to 3/60, allowing limited...
A New Way to Close the Pediatric Mental Health Gap
University of Michigan Health’s Pediatric Psychiatry Colocalized Consult Clinic (P2C3) embeds child psychiatrists within a pediatric primary‑care setting, allowing residents to treat mental‑health cases alongside specialists. The pilot in 2013 served 66 patients, cutting referral wait times to one‑to‑three weeks...
Factors Associated with SARS-CoV-2 Infection Among Healthcare Workers: A European Multicentre Cohort Study, May 2021–April 2024
A European multicentre cohort of 18 hospitals tracked 4,705 healthcare workers from May 2021 to April 2024, dividing the data into pre‑Omicron, Omicron, and post‑Omicron periods. The analysis revealed that ancillary personnel faced the highest infection risk before Omicron (aHR 3.86) and that...
Science Spotlight: Three Teams Converge on RNU2‑2 as Targetable for Neurodevelopmental Epilepsies
Three independent research teams reported in Nature Genetics that variants in the non‑coding RNA RNU2‑2 cause both a dominant neurodevelopmental epilepsy syndrome and a prevalent recessive childhood disorder with epilepsy. By analyzing overlapping international cohorts and shared genomic datasets, they...
Sunshine Biopharma Inc (SBFM) Q4 2025 Earnings Call Transcript
Sunshine Biopharma reported a $713 million cash balance and zero debt at year‑end, while GAAP operating expenses fell to $225 million, driven by lower stock‑based compensation. The company’s Biologics License Application for ivonesumab in EGFR‑mutant NSCLC was accepted by the FDA, with...
Vietnam’s New AI Robot Cuts Bone to Millimetre Accuracy While the Surgeon Watches
Tam Anh General Hospital in Ho Chi Minh City has become Vietnam's first site to use the CUVIS‑Joint AI surgical robot, making the country the ninth worldwide to deploy the fully autonomous knee and hip replacement system. Developed by South...
Amazon Teams Up with Berry Street to Expand Access to Nutrition Therapy
Amazon has incorporated nutrition‑therapy platform Berry Street into its Health Benefits Connector, a marketplace that links employees with employer‑covered digital health services. When shoppers look for nutrition products, the connector promotes Berry Street’s virtual dietitian network of about 1,500 clinicians covering weight...
Reforming Public Health in India: A Roadmap to Universal Health Coverage
India’s public health system, despite its nationwide reach, still fails to provide free, high-quality universal health coverage. The Lancet Commission on a Citizen‑Centred Health System for India, launched in 2020, outlines six reform actions to transform the public sector, emphasizing...
CDC Releases Report on Flu, COVID-19 Vaccination Coverage for Health Care Workers for 2024-25 Respiratory Season
The CDC released its 2024‑25 respiratory‑season report showing that 76.3% of health‑care workers received flu shots and 40.2% were vaccinated against COVID‑19. Coverage rose when employers provided on‑site vaccinations, reaching 73% for flu and 42.9% for COVID‑19, versus 41.4% and...
FAQ Addresses Enforcement Discretion for Plan Compliance Under Certain No Surprises Act Provisions
The Centers for Medicare & Medicaid Services, together with Labor, Treasury and OPM, issued a joint FAQ on April 1 confirming that they will keep using enforcement discretion for No Surprises Act compliance when plans calculate qualifying payment amounts (QPAs) with...
New Study Links Obstructive Sleep Apnea to Increased Risk of Mortality and Cardiovascular Events
A new retrospective study presented at ECO 2026 examined 20,300 adults with obstructive sleep apnea (OSA) against 97,412 matched controls in North‑West London. Over up to four years of follow‑up, OSA patients experienced a 71% higher risk of cardiovascular events or...
CMS Seeks Applicants for LEAD ACO Model
The Centers for Medicare & Medicaid Services (CMS) announced a call for applications to its new LEAD ACO Model, an innovative Medicaid‑focused accountable care organization initiative. The model, launched by the CMS Innovation Center, targets improvements in care coordination for...
![[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/26ba616f3e3f2861b999eb892835dbac.webp)
[Comment] Targeted Advertising in Generative Artificial Intelligence Chatbots: A New Public Health Risk
OpenAI announced it will embed targeted advertising in the free and low‑cost versions of ChatGPT, pairing the rollout with safeguards such as ad‑response separation, privacy protections, age gating for users under 18, and limits on health‑related ads. The move addresses...
![[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/4b3ad670d67640fd05398f327e60ff90.webp)
[Comment] Rethinking Country Classifications Towards a More Equitable Global Health Future
The authors argue that the World Bank’s income‑based country classification, which groups nations into low, middle and high income based on gross national income per capita, no longer reflects health system realities. They show that income alone masks profound heterogeneity...
Large-Scale Study Links Autoimmune Diseases to Higher Rates of Depression and Anxiety
Researchers analyzing data from 1.5 million UK adults found that individuals with autoimmune diseases are almost twice as likely to have been diagnosed with depression, anxiety or bipolar disorder compared with the general population. After adjusting for pain, social isolation and...
![[UPDATED] CMS Proposes 2.4% Hospice Rate Increase for 2027](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hospicenews.com/wp-content/uploads/sites/6/2023/02/washington-monument-1628558_1280.jpg)
[UPDATED] CMS Proposes 2.4% Hospice Rate Increase for 2027
The U.S. Centers for Medicare & Medicaid Services (CMS) has proposed a 2.4% payment increase for hospice providers in fiscal year 2027, translating to roughly $785 million in additional funding. The hospice per‑patient cap would rise to $36,210.11, up from $35,361.44...
The Most Common Age Perimenopause Starts, & What You Can Do To Prepare
Perimenopause, the hormonal transition before menopause, typically starts in a woman's 40s and can span seven to ten years. Symptoms are diverse—insomnia, fatigue, mood swings, hot flashes, and more—affecting daily life and often mistaken for other conditions. Awareness remains low;...
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
The Nasdaq’s recent dip into correction territory has renewed focus on defensive, dividend‑paying healthcare stocks. Analysts highlight AbbVie and Amgen as attractive options, citing strong product pipelines, robust margins, and yields above 2.7%. AbbVie’s immunology drugs Skyrizi and Rinvoq are...
Impactful Innovations Reshape Learning and Technology at ACC 2026
The American College of Cardiology’s 2026 meeting highlighted AI’s transition from hype to a practical clinical tool, showcasing nearly 200 FDA‑cleared cardiology algorithms and embedding AI into the conference app. Attendees experienced live, mobile CCTA scans with AI‑driven plaque analysis,...
Biotech Innovation Makes Inroads Against Bleeding Disorders
Biotech breakthroughs have transformed bleeding disorders from fatal diagnoses into manageable chronic conditions, with extended‑half‑life clotting factors, subcutaneous non‑factor drugs, and emerging gene therapies extending dosing intervals to weeks or months. The National Bleeding Disorders Foundation’s Pathway to Cures fund...
When Snoring Is a Signal of Health Risks
Snoring, often dismissed as a harmless nuisance, can be a warning sign of obstructive sleep apnea (OSA), a condition where the airway collapses repeatedly during sleep. Persistent, loud snoring is linked to reduced oxygen levels, triggering stress hormones and elevating...
News 4/3/26
The article forecasts that the Chief Health AI Transformation Officer (CHAITO) role will be downgraded to a director position before being eliminated entirely, with its duties folded into the chief information officer’s portfolio. This shift reflects growing skepticism about proliferating...
Trump's Obesity Drug Plan for Medicare Would Cost Insurers Billions
President Donald Trump’s proposal to add GLP‑1 obesity drugs to Medicare would impose billions of dollars in costs on private insurers during the first year. The administration claims negotiated drug‑price cuts will offset expenses, but a Vanderbilt‑led analysis estimates only...
Association Between PNI and All-Cause Mortality in Ischemic Stroke Patients: A Large-Scale Retrospective Cohort Study
A retrospective cohort of 1,152 ischemic stroke patients in China found the prognostic nutritional index (PNI) to be a strong, independent predictor of all‑cause mortality. Over a median 14.2‑month follow‑up, 96 deaths occurred, and each one‑point rise in PNI lowered...
There’s an Estrogen Patch Shortage. Here’s What to Do If You’re Affected
A nationwide shortage of estrogen patches is leaving many U.S. women without a key menopause treatment. Prescriptions for hormone replacement therapy have surged 86% since 2021, spurred by the FDA’s removal of a black‑box warning in November. The patch’s popularity...
Bodycote Plans to Open a New Heat Treatment Facility in Mexico
Bodycote, the London‑based heat‑treatment specialist, will open a new facility in Apodaca near Monterrey, Mexico, slated to start operations in 2026. The plant expands capacity for case hardening, nitriding, carburizing, carbonitriding and nitrocarburizing, targeting medical, automotive and general industrial customers....
Changemaker Spearheads Ohio's AI Center of Excellence
John Paganini, president of Paguar Informatics and former HIMSS employee, spearheaded the creation of the Northern Ohio HIMSS chapter’s AI Center of Excellence. The new hub now counts 140 members ranging from clinicians to IT leaders. Its mission is to...
Mount Sinai OB-GYN Groups Relocate to 7K SF at 348 Amsterdam Avenue
Mount Sinai’s two OB‑GYN faculty practice groups are moving to a 7,000‑sq‑ft medical office at 348 Amsterdam Avenue on the Upper West Side. The space, formerly a Modell’s sporting‑goods store, is being gutted and will reopen in June with obstetrics,...
Smoked Cannabis Reduces Immediate Alcohol Consumption in Controlled Laboratory Trial
A double‑blind crossover trial with 157 heavy drinkers found that smoking cannabis before alcohol reduced immediate consumption. A moderate THC dose (3.1%) cut intake by 19%, while a higher dose (7.2%) lowered it by 27% compared with placebo. The high‑THC...
Cost-Related Medication Non-Adherence Declined After the Inflation Reduction Act
The Inflation Reduction Act provisions that took effect Jan. 1, 2024, capping out‑of‑pocket drug costs for Medicare beneficiaries, have led to measurable improvements in medication adherence. A NIH‑funded analysis of the National Health Interview Survey compared 2024 responses with 2021‑2023 data and...
Sirolimus DCB in Peripheral Disease Makes Strides in Hard Outcomes: SirPAD
The SirPAD trial showed that a sirolimus‑coated drug‑coated balloon (MagicTouch) significantly lowered major adverse limb events (MALE) to 8.8% versus 15% with uncoated balloons in femoropopliteal and below‑the‑knee peripheral artery disease patients. At one year, the composite of unplanned amputation...
Inside The New Rules Of Home-Based Care Dealmaking
Home‑based care M&A is moving away from the old playbook of rapid, scale‑driven deals toward a more disciplined, data‑rich approach. Buyers now scrutinize billable hours, caregiver KPIs, payer mix and AI technology stacks, while cultural compatibility has become a decisive...
Traveling Soon? What Federal Health Plans Actually Cover
Federal employee health plans, including FEHB and related options, provide varying levels of overseas medical coverage as travel season peaks. Most plans reimburse at in‑network levels but require members to pay upfront and submit claims with translation and currency conversion....
KLAS Research Releases 2026 First Look Report on Abridge Ambient AI for Nursing
KLAS Research gave Abridge Ambient AI for Nursing a 94.3/100 score in its 2026 First Look report, based on early data from nine nurses across six health systems. The AI transcribes spoken observations into EHR flowsheets and links each entry...
Nelson Advisors Invited to Judge and Mentor the QSTP X Merck FemTech Accelerator 2026
Nelson Advisors has been invited to serve as a judge and mentor for the QSTP x Merck FemTech Accelerator 2026, a joint initiative between Qatar Science & Technology Park and Merck. The accelerator will select up to 30 deep‑tech FemTech startups across...
Part 1—Jason Aldred, MD: Understanding Possible Side Effects When Treating Patients with Parkinson’s Disease
Dr. Jason Aldred of Selkirk Neurology highlights the safety profile of Vyalev (foscarbidopa/foslevodopa), a subcutaneous therapy for Parkinson's disease. He notes that injection‑site reactions such as erythema, swelling, tenderness, bruising, and induration are the most common adverse events. Aldred advises...
Q&A: Duke’s Amanda Randles, Ph.D., on the Future of Digital Twin Innovation
Dr. Amanda Randles of Duke University leads the development of HARVEY, a cardiovascular digital‑twin engine that simulates patient‑specific blood flow across the entire vasculature. The platform, originally requiring the world’s largest supercomputer for a single heartbeat, now runs in minutes...
Plug-and-Play Sensor Listens to the Developing Brain
Researchers at North Carolina State University introduced CAMEO, a low‑cost, plug‑and‑play carbon‑nanotube sensor array for human cerebral organoids. The basket‑shaped device houses 12 flexible electrodes, delivering electrophysiological recordings comparable to high‑end systems while costing a fraction of traditional microelectrode arrays....
DOJ Weighs in Favor of Pharma on 340B Dispute
The U.S. Department of Justice filed a brief backing pharmaceutical manufacturers in the ongoing 340B drug‑discount litigation. The brief argues that discounts should be calculated using the average manufacturer price rather than the lowest price, a stance that could curb...
QT Imaging Releases Next Generation of Breast Imaging Software
QT Imaging Holdings launched version 4.5.0 of its breast imaging software, introducing spatially varying deconvolution that sharpens reflection images. The update fuses speed‑of‑sound data with reflection scans, delivering richer tissue characterization and clearer visualization. It also adds optimized reconstruction for...
The Peptide Fad Lures Health Tech
Health‑tech firms are pivoting toward peptide therapeutics as the next growth engine after the blockbuster GLP‑1 weight‑loss drugs. Peptides, which include insulin and GLP‑1, are being explored for obesity, metabolic and chronic disease treatments. Industry analysts project the global peptide...
Two Neutral IVUS Trials in Complex PCI—And One Positive—Spark Debate
Three recent randomized trials compared intravascular ultrasound (IVUS) with angiography for guiding complex percutaneous coronary interventions (PCI). Only DKCRUSH VIII, which focused on true bifurcation lesions, demonstrated a 60% relative reduction in 1‑year target‑vessel failure. The European OPTIMAL and IVUS‑CHIP studies,...
General Device’s User Spotlight: Arizona — Improving Pediatric Patient Care
Phoenix Children’s Hospital upgraded its telecommunications infrastructure with General Device’s CAREpoint ED Workstation to satisfy Arizona Base Hospital certification, enabling advanced life‑support direction for incoming EMS crews. The solution integrates radio voice and video recording, real‑time data monitoring, management reporting,...
GENFIT Reports Full-Year 2025 Financial Results and Provides Corporate Update
GENFIT reported 2025 results with cash €101.1 million (~$109 million) and revenue €65.4 million (~$70.6 million), the bulk coming from Ipsen milestones and royalties. Iqirvo® generated $208 million in full‑year sales, triggering a $20 million commercial milestone and activating an additional €30 million (~$32 million) royalty‑financing tranche. The...
UK and US Lock in Pharmaceutical Deal
The United Kingdom and the United States have finalized the legal text of a landmark pharmaceutical partnership that eliminates import tariffs on U.S. medicines and certain medical technologies for at least three years. The agreement arrives amid heightened diplomatic tension,...
Aspect Biosystems – Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
Aspect Biosystems secured a CAD $79 million (≈ $58 million USD) investment from the Government of Canada, funding a CAD $280 million (≈ $204 million USD) multi‑year project to accelerate its bioengineered cellular medicines pipeline. The funding builds on a prior CAD $200 million (≈ $146 million USD) co‑investment announced in 2024 and will expand...
AI Scribe Adoption Linked to Modest Reductions in EHR, Documentation Time: Study
A new JAMA study of more than 8,500 clinicians across five academic medical centers found that using AI‑powered scribes shaved 13 minutes off daily EHR use and 16 minutes off documentation time per provider. The efficiency boost translated into a...
Nearly 1 in 4 Pregnant Women Are Skipping Early Prenatal Care. A Veteran Nurse Explains Why that Should Worry All...
A CDC report shows first‑trimester prenatal visits dropped from 78.3% in 2021 to 75.5% in 2024, while women receiving very late or no care rose from 6.3% to 7.3%. The decline is most pronounced among Black, Native Hawaiian‑Pacific Islander, and...